期刊文献+

气相色谱-质谱联用法同时检测7种新型合成大麻素 被引量:4

Simultaneous determination of seven new synthetic cannabinoids by gas chromatography-mass spectrometry
原文传递
导出
摘要 建立优化的气相色谱-质谱联用(GC/MS)法同时对7种新型合成大麻素定性定量检测,并进行方法学评价,对目标物的碎片离子碎裂方式进行分析。选择HP-5MS(30 m×0.25 mm×0.25μm)色谱柱,起始温度200℃(保持1 min),以20℃/min升温至260℃(保持1 min),再以5℃/min升温至300℃(保持10 min),7种目标物能够有效分离,并且在10~400μg/mL范围内均呈良好线性,方法检出限0.40~2.50μg/mL。混合标准溶液的高、中、低浓度日内相对标准偏差(RSD)均小于4.5%,日间RSD均小于8.3%。经案件样本检验证实,该方法适用于实际案件中合成大麻素类物质的定性定量检验鉴定。 An optimized gas chromatography-mass spectrometry(GC/MS)method was established for the qualitative and quantitative detection of seven new synthetic cannabinoids.The fragmentation modes of the target compounds were analyzed and the methodology was evaluated.An HP-5MS(30 m×0.25 mm×0.25μm)column was selected.The initial temperature of the column temperature program was set as 200℃(hold 1 min),ramped up to 260℃at a rate of 20℃/min,holding for 1 min,then up to 300℃at a rate of 5℃/min,holding for 10 min.The results showed that the 7 target substances could be separated effectively with good linearities in the range of 10-400μg/mL.The detection limits were in the range of 0.40-2.50μg/mL.The intra-day relative standard deviations(RSDs)were less than 4.5%and the inter-day RSDs were less than 8.3%.The method could be applied to the qualitative and quantitative identification of synthetic cannabinoid substances in actual cases.
作者 宋辉 李想 朱昱 张婷 赵鹏程 SONG Hui;LI Xiang;ZHU Yu;ZHANG Ting;ZHAO Pengcheng(Department of Forensic Science and Tech-nology,Criminal Investigation Police University of China,Shenyang 110854,China)
出处 《分析试验室》 EI CAS CSCD 北大核心 2022年第8期947-952,共6页 Chinese Journal of Analysis Laboratory
基金 辽宁省教育厅科学研究经费面上项目(LJKZ0071)资助。
关键词 气相色谱-质谱联用法 合成大麻素 碎片离子 定性定量分析 gas chromatography-mass spectrometry synthetic cannabinoid fragment ions qualitative and quan⁃titative analysis
  • 相关文献

参考文献6

二级参考文献30

  • 1Unite Nations Office on Drugs and Crime.The challenge of new psychoactive substances[M].Vienna,2013:19-25.
  • 2EMCDDA.2009 thematic paper-understanding the“Spice”phenomenon[M].Luxembourg Office for Official Publications of the European Communities,2009:3-5.
  • 3Vardakou I, Pistos C, Spiliopoulou C. Toxicol. Lett. , 2010, 197(3) : 157 -162.
  • 4ElSohly M A, Gul W, Wanas A S, Radwan M M. Wanas Life Sciences, 2014, 97 (1) : 78 -90.
  • 5Dowling G, Regan L. J. Chromatogr. B, 2011, 879(3/4) : 253 -259.
  • 6Huffman J W, Dai D, Martin B R, Compton D R. Bioorg. Med. Chem. Lett., 1994, 4(4) : 563 -566.
  • 7Gregori A, Damiano F, Bonavia M, Mileo V, Varani F, Monfreda M. Science and Justice, 2013, 53 (3) : 286 - 292.
  • 8Kavanagh P, Grigoryev A, Melnik A, Savchuk S, Simonov A, Rozhanets V. J. Chromatogr. B, 2013, 934 : 102 - 108.
  • 9Emerson B, Durham B, Gidden J, Lay Jr J D. J. Forensic Sci. Int. , 2013, 229(1/3) : 1 -6.
  • 10Merola G, Aturki Z, D'Orazio G, Gottardo R, Macchia T, Tagliaro F, Fanali S. J. Pharm. Biomed. Anal., 2012, 71 : 45 -53.

共引文献59

同被引文献37

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部